Published on in Vol 23 , No 12 (2021) :December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/34051, first published .
Citation Advantage of Promoted Articles in a Cross-Publisher Distribution Platform: 36-Month Follow-up to a Randomized Controlled Trial

Citation Advantage of Promoted Articles in a Cross-Publisher Distribution Platform: 36-Month Follow-up to a Randomized Controlled Trial

Citation Advantage of Promoted Articles in a Cross-Publisher Distribution Platform: 36-Month Follow-up to a Randomized Controlled Trial

Journals

  1. Nishikawa-Pacher A. Measuring serendipity with altmetrics and randomness. Journal of Librarianship and Information Science 2022:096100062211243 View
  2. Saravudecha C, Na Thungfai D, Phasom C, Gunta-in S, Metha A, Punyaphet P, Sookruay T, Sakuludomkan W, Koonrungsesomboon N. Hybrid Gold Open Access Citation Advantage in Clinical Medicine: Analysis of Hybrid Journals in the Web of Science. Publications 2023;11(2):21 View
  3. Wang X, Gui H, Liu J. How authors evaluate the novelty of their articles: A comparative analysis of highlights in research articles. Journal of Information Science 2023:016555152311669 View